Growth Capitalist (https://growthcapitalist.com/tag/venture-capital/page/3/)
JMP Group’s (JMP) Harvest Capital Strategies unit recently raised $245 million for a fund that will exclusively investment in companies using biotechnology developed by Intrexon Corp. (XON).
As deep-pocketed private investors compete for mega-sized rounds in hot startups, many regional and midsize funds are looking farther afield to find value.
The Financial Industry Regulatory Authority said that private placements and offerings under Regulation A+ will be among its regulatory priorities in 2016.
The securities industry’s self-regulatory organization released its annual Regulatory and Examination Priorities letter on Tuesday, Jan. 5.
Private company insiders will be able to sell their stock only three months after exercising options, rather than one year, under legislation approved Dec. 4.
